Announcements Trials
Browse Landscape

Phase

Phase 2 24Phase 3 11Phase 1/2 5Phase 1 4Phase NA 3Phase EARLY_PHASE1 1Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1

Interventions

Oncolytic Virotherapy 4Magnetic Resonance Spectroscopy 3Fluorodeoxyglucose F18 3Tobacco Use Cessation Devices 2Positron-Emission Tomography 2perflutren 1pembrolizumab 1osimertinib 1icotinib 1gallium 68 PSMA-11 1dapagliflozin 1dacomitinib 1clevudine 1aldesleukin 1Vitamin A 1Tomography, Emission-Computed, Single-Photon 1Tetrahydrouridine 1Technetium 1Sulfur Hexafluoride 1Sufentanil 1Standard of Care 1Specimen Handling 1Ropivacaine 1Radiotherapy 1Radiosurgery 1Probiotics 1Practice Guidelines as Topic 1Positron Emission Tomography Computed Tomography 1Pentetic Acid 1Nicotine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lung Neoplasms × Gefitinib × Clear all
NCT07458919 2026-03-09

Therapy for Advanced NSCLC With EGFR 19delins Mutation

Fuzhou General Hospital

Phase EARLY_PHASE1 Not yet recruiting
94 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡